Correlation between the fucose content / galactose content ratio of antirhesus-D and anti-HLA-DR antibodies and the ADCC activity

Details for Australian Patent Application No. 2004283924 (hide)

Owner LFB Biotechnologies

Inventors Jorieux, Sylvie; Bourel, Dominique; Bihoreau, Nicolas; De Romeuf, Christophe; Nony, Emmanuel

Agent Davies Collison Cave

Pub. Number AU-B-2004283924

PCT Pub. Number WO2005/040221

Priority 0312229 20.10.03 FR

Filing date 20 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 2 December 2010

International Classifications

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/34 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040221 Priority application(s): WO2005/040221

15 January 2009 Assignment before Grant

  Laboratoire Francais Du Fractionnement et des Biotechnologies The application has been assigned to LFB Biotechnologies

2 December 2010 Application Accepted

  Published as AU-B-2004283924

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283925-Use of metallic cations to improve functional activity of antibodies

2004283923-Writing instrument with a lateral button